Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy
Year: 2008
Type: article
Source: Journal of Thoracic Oncology
Authors: Thomas J. Lynch, George R. Blumenschein, Jeffrey A. Engelman, Igor Espinoza-Delgado, Ramaswamy Govindan, Jeff Hanke, Nasser H. Hanna, John V. Heymach, Fred R. Hirsch, Pasi A. Janne, Rogerio C. Lilenbaum, Ronald B. Natale, Gregory J. Riely, Lecia V. Sequist, Geoffrey I. Shapiro, Alice Shaw, Frances A. Shepherd, Mark Socinski, A Gregory Sorensen, Heather A. Wakelee, Aaron Weitzman
Institutions: Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, National Institutes of Health, National Cancer Institute, Washington University in St. Louis, AstraZeneca (United Kingdom), AstraZeneca (United States), Indiana University School of Medicine, University of Colorado Cancer Center, University of Colorado Denver, Dana-Farber Cancer Institute, Mount Sinai Medical Center, Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center, Massachusetts Institute of Technology, Princess Margaret Cancer Centre, University of North Carolina at Chapel Hill, Harvard University, Athinoula A. Martinos Center for Biomedical Imaging, Stanford Medicine, Stanford University, Genentech
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1992574422